Merck’s Biotech Manufacturing Facility Expansion, Aubonne, Switzerland

3l-Image—Merck’s-Biotech-Manufacturing
Investigational cancer candidate M7824 (bintrafusp alfa) will be developed in the new facility. Image courtesy of Merck.